Interleukin-1β downregulates RBP4 secretion in human adipocytes

Area of Science:

• Metabolic research
• Adipose tissue biology
• Inflammation and immunity

Background:

• Obesity is linked to metabolic dysfunction and chronic inflammation.
• Retinol-binding protein 4 (RBP4) is implicated in obesity-related insulin resistance.
• The regulation of RBP4 by adipose tissue inflammation is not fully understood.

Purpose of the Study:

• To investigate whether the inflammatory microenvironment in adipose tissue influences RBP4 expression and secretion.
• To identify specific inflammatory factors involved in RBP4 regulation within adipose tissue.

Main Methods:

• Used human SGBS and primary adipocytes exposed to macrophage-conditioned media and inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8).
• Quantified RBP4 mRNA and protein levels using qPCR and ELISA.
• Assessed the role of IL-1 receptor and NF-κB signaling pathways.
• Correlated IL-1β and RBP4 mRNA expression in human subcutaneous adipose tissue samples.

Main Results:

• Macrophage-conditioned media and IL-1β significantly downregulated RBP4 mRNA and secretion in adipocytes.
• IL-1β's inhibitory effect was mediated through the IL-1 receptor and NF-κB signaling.
• RBP4 mRNA levels were negatively correlated with IL-1β mRNA in human adipose tissue.
• Other tested cytokines (TNF-α, IL-6, IL-8) did not show significant effects on RBP4.

Conclusions:

• Adipose tissue inflammation, characteristic of obesity, can lead to reduced local RBP4 levels.
• Interleukin-1 beta (IL-1β) is a key inflammatory mediator responsible for decreasing RBP4 expression.
• The observed increase in circulating RBP4 in systemic insulin resistance is likely independent of adipose tissue inflammation.